Hubert de Verneuil
Overview
Explore the profile of Hubert de Verneuil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
881
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lefebvre T, Millot S, Richard E, Blouin J, Lalanne M, Lamrissi-Garcia I, et al.
Biochem Biophys Res Commun
. 2019 Oct;
520(2):297-303.
PMID: 31601421
Clinical severity is heterogeneous among patients suffering from congenital erythropoietic porphyria (CEP) suggesting a modulation of the disease (UROS deficiency) by environmental factors and modifier genes. A KI model of...
2.
Wolff F, de Verneuil H, Rucheton B, Lefebvre T, Vialaret J, Ropert-Bouchet M, et al.
Ann Biol Clin (Paris)
. 2018 Sep;
76(6):705-715.
PMID: 30257815
Hepcidin has progressively become essential in clinical practice for the diagnosis and follow-up of a large spectrum of diseases. Anyway, its own biochemical and structural characteristics have complicated and delayed...
3.
Urquiza P, Lain A, Sanz-Parra A, Moreno J, Bernardo-Seisdedos G, Dubus P, et al.
Sci Transl Med
. 2018 Sep;
10(459).
PMID: 30232228
Congenital erythropoietic porphyria is a rare autosomal recessive disease produced by deficient activity of uroporphyrinogen III synthase, the fourth enzyme in the heme biosynthetic pathway. The disease affects many organs,...
4.
Blouin J, Bernardo-Seisdedos G, Sasso E, Esteve J, Ged C, Lalanne M, et al.
Hum Mol Genet
. 2017 Mar;
26(8):1565-1576.
PMID: 28334762
Congenital erythropoietic porphyria (CEP) is an inborn error of heme biosynthesis characterized by uroporphyrinogen III synthase (UROS) deficiency resulting in deleterious porphyrin accumulation in blood cells responsible for hemolytic anemia...
5.
Bedel A, Beliveau F, Lamrissi-Garcia I, Rousseau B, Moranvillier I, Rucheton B, et al.
Stem Cells Transl Med
. 2017 Feb;
6(2):382-393.
PMID: 28191782
Iatrogenic tumorigenesis is a major limitation for the use of human induced pluripotent stem cells (hiPSCs) in hematology. The teratoma risk comes from the persistence of hiPSCs in differentiated cell...
6.
Millot S, Delaby C, Moulouel B, Lefebvre T, Pilard N, Ducrot N, et al.
Haematologica
. 2017 Feb;
102(2):260-270.
PMID: 28143953
Hemolysis occurring in hematologic diseases is often associated with an iron loading anemia. This iron overload is the result of a massive outflow of hemoglobin into the bloodstream, but the...
7.
Vendrely V, Peuchant E, Buscail E, Moranvillier I, Rousseau B, Bedel A, et al.
Cancer Lett
. 2017 Jan;
390:91-102.
PMID: 28089829
Pancreatic adenocarcinoma, highly resistant to all current anti-cancer treatments, necessitates new approaches promoting cell death. We hypothesized that combined actions of several Bioactive Food Components (BFCs) might provide specific lethal...
8.
Bensenouci S, Louhibi L, de Verneuil H, Mahmoudi K, Saidi-Mehtar N
Biomed Res Int
. 2016 Jul;
2016:2180946.
PMID: 27413738
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder. Considering that XP patients have a defect of the nucleotide excision repair (NER) pathway which enables them to repair DNA damage...
9.
Callebaut I, Joubrel R, Pissard S, Kannengiesser C, Gerolami V, Ged C, et al.
Hum Mol Genet
. 2014 Apr;
23(17):4479-90.
PMID: 24714983
Hemochromatosis type 4 is a rare form of primary iron overload transmitted as an autosomal dominant trait caused by mutations in the gene encoding the iron transport protein ferroportin 1...
10.
Oustric V, Manceau H, Ducamp S, Soaid R, Karim Z, Schmitt C, et al.
Am J Hum Genet
. 2014 Apr;
94(4):611-7.
PMID: 24680888
In 90% of people with erythropoietic protoporphyria (EPP), the disease results from the inheritance of a common hypomorphic FECH allele, encoding ferrochelatase, in trans to a private deleterious FECH mutation....